| Literature DB >> 28780001 |
Janina Tokarz1, Mark Haid1, Alexander Cecil1, Cornelia Prehn1, Anna Artati1, Gabriele Möller1, Jerzy Adamski2.
Abstract
The metabolome, although very dynamic, is sufficiently stable to provide specific quantitative traits related to health and disease. Metabolomics requires balanced use of state-of-the-art study design, chemical analytics, biostatistics, and bioinformatics to deliver meaningful answers to contemporary questions in human disease research. The technology is now frequently employed for biomarker discovery and for elucidating the mechanisms underlying endocrine-related diseases. Metabolomics has also enriched genome-wide association studies (GWAS) in this area by providing functional data. The contributions of rare genetic variants to metabolome variance and to the human phenotype have been underestimated until now.Entities:
Keywords: GWAS; biostatistics; endocrinology; genomics; mass spectrometry; metabolomics
Mesh:
Year: 2017 PMID: 28780001 DOI: 10.1016/j.tem.2017.07.001
Source DB: PubMed Journal: Trends Endocrinol Metab ISSN: 1043-2760 Impact factor: 12.015